No Data
No Data
Kangwei Century (688426.SH): Four shareholders collectively reduced their holdings by 0.414 million shares.
Kangwei Century (688426.SH) announced that on September 30, 2024, the company received a notice from the jiangsu shareholder...
2024 Semi-Annual Report
2024 Semi-Annual Report Summary
Kangweicentury (688426.SH) released its semi-annual performance report, with a net loss of 50.06 million yuan.
Kangwe Century (688426.SH) disclosed its 2024 interim report, during which the company achieved revenue of 6715...
Kangwei Century (688426.SH): net loss of 50.0569 million yuan in the first half of the year.
On August 29, Gelunhui announced that Kangweishiji (688426.SH) released its 2024 interim report. During the reporting period, it achieved revenue of 67.1466 million yuan, a year-on-year decrease of 44.76%; achieved a net income attributable to the company's shareholders of -50.0569 million yuan.
Kangweishiji (688426.SH): Obtained CE certification for Monkeypox viral nucleic acid detection kit in the European Union.
On August 16th, Grothron reported that Kangweishiji (688426.SH) stated on the interactive platform that in 2022, the company obtained a CE certification for monkeypox virus nucleic acid detection kit (fluorescence PCR method) used to test monkeypox virus in the European Union (CE certification is a mandatory product certification in the European Union and a passport for products to enter the European market). It is expected that the contribution of this product to revenue in 2024 may be negligible.
No Data
No Data